Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001912516 | SCV002158558 | pathogenic | not provided | 2024-11-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu1164*) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with EYS-related conditions. ClinVar contains an entry for this variant (Variation ID: 1393212). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003471006 | SCV004193563 | likely pathogenic | Retinitis pigmentosa 25 | 2022-09-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV003471006 | SCV005670617 | likely pathogenic | Retinitis pigmentosa 25 | 2024-03-21 | criteria provided, single submitter | clinical testing |